EP Patent

EP1165054A4 — Pharmaceutical dosage form for pulsatile delivery of methylphenidate

Assigned to Pharmaquest Ltd · Expires 2005-02-09 · 21y expired

What this patent protects

Novel pharmaceutical dosage forms provide for pulsatile delivery of methylphenidate, i.e., release encapsulated drug in spaced apart 'pulses'. The dosage forms are comprised of first, second and optionally third dosage units, with each dosage unit having a different drug release …

USPTO Abstract

Novel pharmaceutical dosage forms provide for pulsatile delivery of methylphenidate, i.e., release encapsulated drug in spaced apart 'pulses'. The dosage forms are comprised of first, second and optionally third dosage units, with each dosage unit having a different drug release profile. The dosage forms may comprise capsules housing compressed tablets or drug-containing beads or particles, or may comprise a single tablet with the first, second and optionally third dosage units each representing an integral and discrete segment thereof. Methods of treatment using the pharmaceutical dosage forms are provided as well.

Drugs covered by this patent

Patent Metadata

Patent number
EP1165054A4
Jurisdiction
EP
Classification
—
Expires
2005-02-09
Drug substance claim
No
Drug product claim
No
Assignee
Pharmaquest Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.